Contact between a polymer and whole blood: Sequence of events leading to thrombin generation

Journal of Laboratory and Clinical Medicine

Volumn 138, Issue 2, 2001, Pages 139-145

  Hong, Jaan ^a,b   Larsson, Anders ^a,b   Ekdahl, Kristina Nilsson ^a,b   Elgue, Graciela ^a,b   Larsson, Rolf ^a,b   Nilsson, Bo ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034926666     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.116486     Document Type: Article

References (34)

1. Cell matrix reactions at titanium implants in surgically prepared rat tibiae
2. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin
3. Tubing loops as a model for cardiopulmonary bypass circuits: Both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model
4. Role of fibrinogen in activation of platelets by artificial surfaces
5. Adsorption of coagulation proteins from whole blood on to polymer materials: Relation to platelet activation
6. Titanium is a highly thrombogenic biomaterial: Possible implications for osteogenesis
7. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response
8. Platelets and factor XI bypass the contact system of blood coagulation
9. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay
10. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression
11. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation
12. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin
13. Effect of surface-immobilized heparin on the activation of adsorbed factor XII
14. Assay for Hageman factor (factor XII) in human plasma by means of chromogenic substrate for plasma kallikrein
15. Structure and function of platelet membrane glycoproteins Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin
16. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases
17. Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes
18. Activation of coagulation and platelets is affected by the hydrophobicity of artificial surfaces
19. Coagulation on biomaterials in flowing blood: Some theoretical considerations
20. Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2
21. Effects of a new platelet glycoprotein IIb/IIIa antagonist, SR121566, on platelet activation, platelet-leukocyte interaction and thrombin generation
22. Comparative study of antiplatelet drugs in vitro: Distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses
23. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa
24. Phosphorylation of coagulation factor XI by a casein kinase released by activated human platelets increases its susceptibility to activation by factor XIIa and thrombin
25. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia
26. Contribution of erythrocytes to thrombin generation in whole blood
27. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment
28. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment
29. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood
30. A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process
31. Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model
32. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
33. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents
34. Platelet-leukocyte cross talk in whole blood